The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD…
The Neurology Minute podcast is an incredible resource for anyone interested in neurology or seeking to expand their knowledge on the subject. Hosted by Dr. Stacey Clardy, the show excels at taking complex subjects and breaking them down in a way that is understandable to the average person. With episodes lasting just a minute or two, it's an easy listen that can truly change the way one speaks to a patient or even make a diagnosis.
One of the best aspects of The Neurology Minute podcast is its brevity combined with its informative and targeted content backed up by evidence-based science. Each episode provides concise information that is relevant and practical. The guests interviewed on this show are experts in their field, and their insights can have a direct impact on the care of patients. The interviews are thought-provoking and often provide unique perspectives not commonly found elsewhere.
Despite its many strengths, one possible drawback of The Neurology Minute podcast is its short format. While it is great for those who prefer quick learning bites or have limited time available, it may not delve as deeply into certain topics as some listeners would like. However, given that each episode lasts only a minute or two, it still manages to cover a surprising amount of information.
In conclusion, The Neurology Minute podcast is a must-listen for anyone interested in neurology or looking to enhance their medical knowledge. It offers concise yet impactful episodes that provide valuable insights from experts in the field. Whether you're a medical student considering neurology as a specialty or simply looking to broaden your understanding of neurological conditions, this podcast delivers high-quality content in bite-sized portions. Don't miss out on this opportunity to learn from some of the best minds in neurology!
Dr. Jason Crowell and Dr. YuHong Fu discuss the importance of differentiating between dementia with Lewy bodies and Parkinson disease dementia. Show citatiion: Fu Y, Halliday GM. Dementia with Lewy bodies and Parkinson disease dementia - the same or different and is it important?. Nat Rev Neurol. 2025;21(7):394-403. doi:10.1038/s41582-025-01090-x
Dr. Dan Ackerman and Dr. Isabel Hostettler discuss the diagnosis, risk factors, and prognosis of RCVS, highlighting the need to recognize symptoms and distinguish it from other causes of subarachnoid hemorrhage. Show reference: Hostettler IC, Ponciano A, Wilson D, et al. Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage: Individual Patient Data Analysis. Neurology. 2025;105(5):e213984. doi:10.1212/WNL.0000000000213984
In the November episode of the President's Spotlight, Dr. Jason Crowell talks with Dr. Natalia Rost about the Centers for Medicare & Medicaid Services final rule for how physicians are reimbursed in 2026. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight
Dr. Aaron Zelikovich discusses a recent article on nipocalimab and its role in treating generalized myasthenia gravis. Show citations: Antozzi C, Vu T, Ramchandren S, et al. Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2025;24(2):105-116. doi:10.1016/S1474-4422(24)00498-8
Dr. Katherine Havard Coiro discusses the 2024 McDonald Criteria for Multiple Sclerosis and how to interpret cerebrospinal fluid. Show reference: Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865
In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Marcelle Lapicque.
Dr. Alison Christy and Dr. Matthew Ryan Woodward discuss the complexities of status epilepticus, focusing on its definitions, the transition to refractory and super-refractory states, and the implications for treatment. Show citation: Woodward MR, Brown JP, Kittner SJ, et al. Super-Refractory Status Epilepticus Diagnosis, Management, and Prognostication: An International Survey Study. Neurol Clin Pract. 2025;15(5):e200520. doi:10.1212/CPJ.0000000000200520
In the second part of this two-part series, Dr. Bradley Ong explains the four clinical phases of a typical migraine attack. Show citation: Lipton RB, Stokes J, Evans CJ, et al. Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing. Headache. 2025;65(8):1355-1368. doi:10.1111/head.15024
In part one of this two-part series, Dr. Bradley Ong discusses the prodrome phase of migraine and how it represents the earliest stage of the attack. Show citation: Lipton RB, Stokes J, Evans CJ, et al. Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing. Headache. 2025;65(8):1355-1368. doi:10.1111/head.15024
In part two of this series, Dr. Stacey Clardy and Dr. Sandra Vukusic discuss gender disparities in the treatment of multiple sclerosis. Show citation: Gavoille A, Leray E, Marignier R, et al. Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis. Neurology. 105(4) e213907. doi:10.1212/WNL.0000000000213907
In part one of this two-part series, Dr. Stacey Clardy and Dr. Sandra Vukusic discuss what disease-modifying therapies can be safely continued and strategically timed when pregnancy is anticipated. Show citation: Gavoille A, Leray E, Marignier R, et al. Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis. Neurology. 105(4) e213907. doi:10.1212/WNL.0000000000213907
Dr. Alison Christy and Dr. Jennifer L. McGuire discuss neuroimaging findings linked to ICANS, exploring whether specific imaging patterns correlate with distinct neurologic symptoms. Show citation: McGuire JL, Pinto S, Erdogan EN, et al. Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell Malignancies. Neurology. 2025;105(7):e214086. doi:10.1212/WNL.0000000000214086
Dr. Alison Christy and Dr. Jennifer L. McGuire discuss neuroimaging findings linked to ICANS, exploring whether specific imaging patterns correlate with distinct neurologic symptoms. Show citation: McGuire JL, Pinto S, Erdogan EN, et al. Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell Malignancies. Neurology. 2025;105(7):e214086. doi:10.1212/WNL.0000000000214086
In the final episode of this three-part series, Dr. Jeff Lambe addresses practical considerations surrounding the inclusion of the optic nerve as a topography for demonstrating dissemination in space. Show citation: Montalban X, Lebrun-Frénay C, Oh J, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850-865. doi:10.1016/S1474-4422(25)00270-4
In part two of this three-part series, Dr. Jeff Lambe outlines how the optic nerve is being incorporated as one of five topographies used to demonstrate dissemination in space. Show citation: Montalban X, Lebrun-Frénay C, Oh J, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850-865. doi:10.1016/S1474-4422(25)00270-4
In part one of this three-part series, Dr. Jeff Lambe discusses the rationale for including the optic nerve in the 2024 revisions to the McDonald criteria. Show citation: Montalban X, Lebrun-Frénay C, Oh J, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850-865. doi:10.1016/S1474-4422(25)00270-4
Dr. Katie Krulisky and Dr. Stefano Meletti discuss the incidence and characteristics of postictal central apnea in focal seizures. Show citation: Meletti S, Burani M, Ballerini A, et al. Persistent Postictal Central Apnea in Focal Seizures: Incidence, Features, and Imaging Findings. Neurology. 2025;105(4):e213856. doi:10.1212/WNL.0000000000213856
Dr. Greg Cooper and Dr. Claudia Suemoto discuss the association between consumption of low- and no-calorie sweeteners and cognitive decline. Show citations: Gonçalves NG, Martinez-Steele E, Lotufo PA, et al. Association Between Consumption of Low- and No-Calorie Artificial Sweeteners and Cognitive Decline: An 8-Year Prospective Study. Neurology. 2025;105(7):e214023. doi:10.1212/WNL.0000000000214023
Dr. Paul Crane discusses Oropouche virus and its neurologic complications.
In the second part of this two-part series, Dr. Kaitlyn Palmer explains how these biomarkers change our approach to diagnosing multiple sclerosis. Show reference: Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865
In part one of this two-part series, Dr. Kaitlyn Palmer discusses two new MRI biomarkers to increase diagnostic specificity for multiple sclerosis. Show reference: Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865
Dr. Katie Krulisky and Dr. Rosemary Dray-Spira discuss the trends in prenatal exposure to antiseizure medications over the past decade. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213933 Citation: Pouneh S, Jérôme D, Sara M, et al. Trends in Prenatal Exposure to Antiseizure Medications Over the Past Decade: A Nationwide Study. Neurology. 2025;105(4): e213933.
Dr. Greg Cooper and Dr. Jonathan Graff-Redford discuss the key takeaways from the recent Alzheimer's Association International Conference (AAIC).
Dr. Margarita Fedorova discusses whether living near a golf course impacts the risk of Parkinson disease. Show reference: Krzyzanowski B, Mullan AF, Dorsey ER, et al. Proximity to Golf Courses and Risk of Parkinson Disease. JAMA Netw Open. 2025;8(5):e259198. doi:10.1001/jamanetworkopen.2025.9198
In the second episode of this two-part series, Dr. Justin Abbatemarco and Dr. Jennifer E. Fugate discuss patient outcomes and how to manage these individuals both in the hospital and outside the hospital. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00232-7/abstract
In the first episode of this two-part series, Dr. Justin Abbatemarco and Dr. Jennifer E. Fugate discuss posterior reversible encephalopathy syndrome (PRES), highlighting both typical and atypical MRI findings. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00232-7/abstract
Dr. Gregg Day and Drs. Laura Baker and Melissa Yu discuss interventions that enhance or safeguard cognitive function in older adults at risk of cognitive decline and dementia. Show reference: https://jamanetwork.com/journals/jama/article-abstract/2837046
In the second part of this two-part series, Casey Kozak concludes the discussion about the TOAST criteria for classifying acute ischemic stroke.
In the first part of this two-part series, Casey Kozak discusses the TOAST criteria for classifying acute ischemic stroke. In this episode, she covers large artery atherosclerosis and small vessel disease.
In the final episode of this five-part series, Dr. Paul Crane concludes the measles series by discussing testing and prevention.
In the fourth episode of this five-part series, Dr. Paul Crane discusses subacute sclerosing panencephalitis, a serious complication of measles.
Dr. Jessica Ailani and Dr. Kathleen Digre discuss three key updates in the understanding and management of idiopathic intracranial hypertension. Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2836065 https://www.neurology.org/doi/10.1212/WNL.0000000000009312
Dr. Andy Southerland and Dr. Amrou Sarraj examine whether general anesthesia (GA) compared with non-GA was associated with better functional outcomes in the SELECT2 trial. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213819
In the October episode of the President's Spotlight, Dr. Jason Crowell talks with Dr. Natalia Rost about the crucial role research plays in neurology for clinicians and scientists. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight
In this episode, Dr. Andy Southerland discusses the Capitol Hill Report from October 6th, covering the government shutdown and its potential impact on you and your patients. Stay updated with what's happening on the hill by visiting aan.com/chr. Take a minute to email your members of Congress and ensure your voice is heard!
In the second episode of this two-part series, Dr. Kiran Thakur and Dr. Ava Easton discuss how to get involved in advocacy efforts and policy development related to encephalitis. Show reference: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00057-6/fulltext
In part one of this two-part series, Dr. Kiran Thakur and Dr. Ava Easton discuss the World Health Organization's technical brief on encephalitis. Show reference: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00057-6/fulltext
In the third episode of this five-part series, Dr. Paul Crane discusses measles inclusion body encephalitis.
In the third episode of this five-part series, Dr. Paul Crane discusses measles inclusion body encephalitis.
In the second part of this five-part series, Dr. Paul Crane discusses the early neurologic complications associated with measles.
In the first part of this five-part series, Dr. Paul Crane discusses the reemergence of measles and outlines steps to take if you suspect someone may have measles.
In this episode, Dr. Andy Southerland discusses the Capitol Hill Report from September 8, providing important updates around BrainPAC. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Dr. Deanna Saylor and Dr. Senjuti Saha discuss colonialism in global health and the importance of pathogen genomics. Show reference: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(24)00091-8/fulltext
In the final episode of this two-part series, Dr. Justin Abbatemarco discusses long-term maintenance therapy options. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200504
In part one of this two-part series, Dr. Justin Abbatemarco discusses what we know and don't know surrounding MOG antibody–associated diseases (MOGADs). Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200504
In the final part of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss how to approach discontinuation of immunotherapy in clinical practice. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213903
In part two of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss a long-term maintenance approach for MOGAD. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213903
In part two of this two-part series, Dr. Robert Holloway and Dr. Carolyn Rennels discuss the future of addressing intolerable suffering in practice and explore the opportunities for MAID. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200478
In part one of this two-part series, Dr. Robert Holloway and Dr. Carolyn Rennels discuss the main takeaway points from the paper. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200478
Dr. Justin Abbatemarco and Dr. Aaron Zelikovich discuss the safety and efficacy of satralizumab and its role in the current treatment landscape for myasthenia gravis. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00514-3/fulltext
Dr. Bradley Ong discusses the efficacy and safety of fremanezumab in adults with migraine and comorbid major depressive disorder. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2833452
© 2020-2025 Ivy Podcast Discovery LLC
